USANA HEALTH SCIENCES INC
USNANYSEHealthcare · Medicinal Chemicals & Botanical Products · UT · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY26 | FY24 | FY23 | FY22 | FY21 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $925.3M | $854.5M | $921.0M | $1.19B | $1.13B | $1.06B |
| Operating income | $37.4M | $66.3M | $93.1M | $170.2M | $176.5M | $146.2M |
| Net income | $10.8M | $42.0M | $63.8M | $116.5M | $124.7M | $24.2M |
| Total assets | $742.9M | $748.2M | $632.8M | $577.7M | $640.9M | $516.9M |
| Total liabilities | $156.6M | $161.9M | $135.6M | — | — | — |
| Equity | $533.1M | $532.1M | $497.2M | $395.1M | $441.6M | $351.7M |
| EPS (diluted) | $0.58 | $2.19 | $3.30 | $5.73 | $5.86 | $1.01 |
| Shares out. | 18.5M | 19.2M | 19.3M | 19.3M | 20.9M | 23.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2026- Operating margin
- 4.0%
- Net margin
- 1.2%
- Return on equity
- 2.0%
- Return on assets
- 1.4%
- Return on capital (ROCE)
- 6.1%
- Liabilities / assets
- 21.1%
- Debt / equity
- 0.29×
- Book value / share
- $28.88
- Revenue growth (YoY)
- 8.3%
- Net income growth (YoY)
- −74.4%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2026- Altman Z″ (distress)
- 7.37safe
- Accruals / assets
- −1.6%clean
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Wentz Myron WActivist (13D)Mar 30, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Blackrock, Inc.Passive (13G)Jan 21, 2026
- Dimensional Fund Advisors LpPassive (13G)Jan 21, 2026
- Pzena Investment Management LlcPassive (13G)Oct 14, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Fleming John TurmanDirector | Jun 1, 2026 | Sell | 2,450 | $17.93 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 595,852 | 4.6 | +18.7% |
| Apr 30, 2026 | 501,916 | 5.3 | +5.0% |
| Apr 15, 2026 | 477,879 | 4.3 | -10.1% |
| Mar 31, 2026 | 531,623 | 3.6 | +17.2% |
| Mar 13, 2026 | 453,571 | 2.8 | +12.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Shareholder voteMay 20, 2026
- Results of operations · Regulation FD disclosureMay 5, 2026
- Results of operations · Regulation FD disclosureFeb 18, 2026
- Results of operations · Regulation FD disclosureJan 12, 2026
- Director / officer change · Regulation FD disclosureJan 8, 2026
- Results of operations · Regulation FD disclosureOct 22, 2025
- Results of operations · Regulation FD disclosureOct 9, 2025
- Results of operations · Regulation FD disclosureJul 22, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.